GlaxoSmithKline PLC Director/PDMR Shareholding (5214Y)
September 09 2020 - 10:11AM
UK Regulatory
TIDMGSK
RNS Number : 5214Y
GlaxoSmithKline PLC
09 September 2020
GlaxoSmithKline plc (the ' Company ')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA')
==== ==============================================================================================
a) Name Mr L Miels
==== ====================================== ======================================================
b) Position/status President, Global Pharmaceuticals
==== ====================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== ======================================================
b) Nature of the Following the vesting on 4 September 2020
transaction of 25% of an award made on 14 February
2018 under the GlaxoSmithKline Deferred
Investment Award Plan, Mr Miels will receive
a cash payment of GBP373,151.97 less applicable
tax withholding in respect of 25,999.998
notional Ordinary Shares.
==== ====================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ======================== =========================
GBP14.352 25,999.998
==================================================================== =========================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================= ================================
e) Date of the transaction 2020-09-04
==== ====================================== ======================================================
f) Place of the N/A
transaction
==== ====================================== ======================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHZKLFBBKLFBBB
(END) Dow Jones Newswires
September 09, 2020 10:11 ET (14:11 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024